Kano
PCN Rejects Kano Taskforce Allegations, Cites Enforcement Record
The Pharmacy Council of Nigeria (PCN) has rejected allegations by the Chairman of the Kano State Multi-Agency Taskforce on Drug Abuse and Illicit Trafficking, Muhuyi Magaji Rimin Gado, accusing the regulatory agency of shielding drug dealers and facilitating the distribution of illicit substances in the state.
The Council described the allegations as unfounded, insisting that it remains committed to enforcing pharmaceutical regulations and combating the unauthorised distribution of medicines.
The rebuttal was contained in a statement issued on Saturday, November 14, 2026, and signed by Pharm. Hasiya Ladan, Consultant Pharmacist at the PCN Kano State Office, on behalf of the Registrar and Chief Executive Officer.
The response followed a press conference addressed by Magaji in Kano, during which he reportedly accused the PCN and the National Agency for Food and Drug Administration and Control (NAFDAC) of aiding and protecting drug dealers.
Read Also:
Kano proposes ₦1.1trn 2027 budget, earmarks 74.5% for five key sectors
Among other allegations, the taskforce chairman reportedly questioned the issuance of import licences to pharmaceutical companies dealing in pregabalin, following its rescheduling as a controlled drug by NAFDAC on September 14, 2026.
He also alleged that the PCN registered a pharmaceutical outlet at No. 10 Apple Avenue, a residential area, which he claimed was being used as a concealed distribution point for the drug.
Magaji further alleged that some PCN officials were involved in clandestine pharmaceutical businesses and questioned the agency’s capacity to enforce regulations, citing its relatively small number of personnel in Kano.
However, the Council dismissed the accusations, maintaining that its regulatory responsibilities are backed by the Pharmacy Council of Nigeria (Establishment) Act 2022 and other relevant legal instruments.
It argued that drugs and poisons fall under the Exclusive Legislative List of the 1999 Constitution, making their regulation a federal responsibility exercised through legally established agencies.
The PCN also cited the Supreme Court judgment in Pharmacists Board of Nigeria v. Franklin Adegbesote (1986), a Federal High Court judgment in Kano delivered on February 16, 2024, and other legal and institutional decisions in support of its position on the regulation of pharmaceutical premises.
On the allegation that it lacked the capacity to regulate pharmaceutical outlets, the Council explained that its inspection and licensing framework operates through established committees in the 36 states and the Federal Capital Territory.
According to the statement, the Pharmaceutical Inspection Committee (PIC) and the Patent and Proprietary Medicines Vendors Licence Committee (PPMVLC) are chaired by Directors of Pharmaceutical Services in state ministries of health.
The committees also comprise representatives of the Pharmaceutical Society of Nigeria, PCN officers and other qualified pharmacists appointed as inspectors.
The PCN explained that its state officers serve as secretaries to the committees and provide administrative support, while inspections and recommendations for licensing are carried out through the established structures.
It maintained that its enforcement capacity was not determined by the number of officers stationed in a particular state, adding that it could mobilise additional personnel whenever necessary.
The Council further said the World Health Organisation had affirmed Nigeria’s regulatory capacity through its Global Benchmarking Assessment, under which the country’s regulatory system attained and retained Maturity Level 3.
On the controversy surrounding pregabalin importation, the PCN clarified that the issuance of import licences to pharmaceutical importation companies falls within its mandate, while NAFDAC is responsible for issuing product permits specifying the categories and quantities of products authorised for importation.
It added that allegations of wrongdoing involving a particular premises would require evidence of illegal drug distribution rather than assumptions based solely on the issuance of regulatory approval.
Regarding the alleged registration of a pharmaceutical outlet in a residential area, the Council said its Pharmaceutical Premises Location, Inspection, Structure, Monitoring and Enforcement Regulations 2022 prescribe the requirements for approving and registering pharmaceutical premises.
It argued that the regulations do not expressly prohibit the registration of pharmaceutical premises in residential areas, provided applicants satisfy the applicable regulatory requirements.
The Council also rejected claims that it had compromised the objectives of the Coordinated Wholesale Centre (CWC), explaining that the initiative was developed by the Federal Government through the Federal Ministry of Health and Social Welfare to address the challenges associated with open drug markets.
According to the statement, the CWC is specifically intended to relocate identified and verified vendors operating in open drug markets, including the Sabon Gari drug market in Kano, and does not prevent independent pharmaceutical wholesalers, distributors, importers and warehouse operators from establishing their own facilities.
The PCN disclosed that its National Enforcement Team had visited 11 states in 2026, with Kano inspected twice, in April and September.
It said the team visited 9,908 pharmaceutical outlets nationwide during the period, sealing 6,838 for various regulatory offences.
In Kano State alone, the Council said 2,304 outlets were inspected, while 1,631 were sealed, with 15 investigations still ongoing. It noted that the figures did not include routine enforcement activities conducted by its state office.
The Council also dismissed allegations that some of its personnel were involved in clandestine pharmaceutical businesses, challenging the taskforce chairman to provide evidence to substantiate the claims.
It said it took allegations of misconduct against its staff seriously and was willing to investigate any credible information submitted through the appropriate channels.
On the monitoring of controlled medicines, the PCN said it had introduced and deployed the Disposal of Poison Records, known as Form K, with support from the United Nations Office on Drugs and Crime (UNODC), NAFDAC and other stakeholders.
The system requires pharmaceutical premises, including hospitals, to document controlled substances sold, distributed or dispensed, with sanctions imposed on facilities found to be negligent in maintaining the required records.
Reaffirming its commitment to public safety, the Council said the fight against illicit drugs and the unauthorised use of controlled medicines required cooperation among regulatory agencies and other stakeholders.
It warned against using the campaign against drug abuse as a platform for institutional intimidation, unfounded accusations or undermining the statutory responsibilities of established regulatory bodies.
The PCN, however, welcomed credible investigations into alleged violations of existing laws, including complaints involving its personnel and registered pharmaceutical premises, and encouraged members of the public to report suspected wrongdoing through its dedicated channels.
-
Education4 days agoKano Polytechnic Council Queries Garun-Danga, Confirms Aikawa, Renews Bursar’s Tenure
-
Education4 days agoKano Polytechnic Council Gives Rector 14 Days to Explain Financial Irregularities
-
Education2 days agoWhy Kano Polytechnic Council Queried Rector Over Financial, Administrative Irregularities
